PharmGKB summary: citalopram pharmacokinetics pathway.
作者信息
Sangkuhl Katrin, Klein Teri E, Altman Russ B
机构信息
Department of Genetics, Stanford University, Stanford, California, USA.
出版信息
Pharmacogenet Genomics. 2011 Nov;21(11):769-72. doi: 10.1097/FPC.0b013e328346063f.
Abstract
摘要
相似文献
1
PharmGKB summary: citalopram pharmacokinetics pathway.药物基因组学知识库总结：西酞普兰的药代动力学途径。
Pharmacogenet Genomics. 2011 Nov;21(11):769-72. doi: 10.1097/FPC.0b013e328346063f.
2
Binding of S-citalopram and paroxetine discriminates between species.S-西酞普兰和帕罗西汀的结合在不同物种间存在差异。
Synapse. 2005 Mar 15;55(4):280-2. doi: 10.1002/syn.20116.
3
N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.N-甲基西酞普兰：一种季铵型选择性 5-羟色胺再摄取抑制剂。
Biochem Pharmacol. 2010 Nov 15;80(10):1546-52. doi: 10.1016/j.bcp.2010.07.035. Epub 2010 Aug 7.
4
Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.与健康受试者相比，中度肾功能不全或肝硬化患者中舍曲林的单剂量药代动力学。
Eur J Clin Pharmacol. 1998 May;54(3):237-42. doi: 10.1007/s002280050452.
5
Pharmacology and pharmacokinetics of citalopram and other SSRIs.西酞普兰及其他选择性5-羟色胺再摄取抑制剂的药理学与药代动力学
Int Clin Psychopharmacol. 1996 Mar;11 Suppl 1:5-11. doi: 10.1097/00004850-199603001-00002.
6
PharmGKB summary: venlafaxine pathway.药物基因组学知识库总结：文拉法辛途径。
Pharmacogenet Genomics. 2014 Jan;24(1):62-72. doi: 10.1097/FPC.0000000000000003.
7
Interaction potential of selective serotonin-reuptake inhibitors.
Am J Health Syst Pharm. 2000 Oct 1;57(19):1802-3. doi: 10.1093/ajhp/57.19.1802a.
8
Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder.组合药物基因组学算法可预测重度抑郁症患者西酞普兰和艾司西酞普兰的代谢情况。
Psychiatry Res. 2020 Aug;290:113017. doi: 10.1016/j.psychres.2020.113017. Epub 2020 May 17.
9
[Medical interactions with antidepressives. Benefits of the specific serotonin reuptake inhibitor citalopram].[抗抑郁药的医学相互作用。特异性5-羟色胺再摄取抑制剂西酞普兰的益处]
Med Monatsschr Pharm. 1998 May;21(5):138-50.
10
Quantitative methods for prediction of the effect of cytochrome P450 gene polymorphisms on substrate drug exposure.
Clin Pharmacokinet. 2015 Mar;54(3):319-20. doi: 10.1007/s40262-014-0217-3.
引用本文的文献
1
Research progress on the synergistic effect and its mechanisms of antidepressants and antibiotics against resistant pathogens.抗抑郁药与抗生素对耐药病原体的协同作用及其机制的研究进展
Arch Microbiol. 2025 May 29;207(7):157. doi: 10.1007/s00203-025-04362-8.
2
Citalopram exposure of hESCs during neuronal differentiation identifies dysregulated genes involved in neurodevelopment and depression.在神经元分化过程中，人胚胎干细胞暴露于西酞普兰可鉴定出参与神经发育和抑郁症的失调基因。
Front Cell Dev Biol. 2024 Jul 11;12:1428538. doi: 10.3389/fcell.2024.1428538. eCollection 2024.
3
Human Data on Pharmacokinetic Interactions of Cannabinoids: A Narrative Review.人类对大麻素药代动力学相互作用的研究数据：综述。
Curr Pharm Des. 2024;30(4):241-254. doi: 10.2174/0113816128288510240113170116.
4
Precision, integrative medicine for pain management in sickle cell disease.用于镰状细胞病疼痛管理的精准、综合医学
Front Pain Res (Lausanne). 2023 Nov 9;4:1279361. doi: 10.3389/fpain.2023.1279361. eCollection 2023.
5
Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know.儿科胃肠病学家的药物遗传学检测：需要了解的可采取行动的药物-基因对。
Pharmaceuticals (Basel). 2023 Jun 16;16(6):889. doi: 10.3390/ph16060889.
6
Understanding target-specific effects of antidepressant drug pollution on molluscs: A systematic review protocol.理解抗抑郁药污染对软体动物的靶向特定效应：系统综述方案。
PLoS One. 2023 Jun 27;18(6):e0287582. doi: 10.1371/journal.pone.0287582. eCollection 2023.
7
The Role of Serotonergic and Noradrenergic Descending Pathways on Performance-Based Cognitive Functioning at Rest and in Response to Exercise in People with Chronic Whiplash-Associated Disorders: A Randomized Controlled Crossover Study.血清素能和去甲肾上腺素能下行通路对慢性挥鞭样损伤相关疾病患者静息及运动时基于表现的认知功能的作用：一项随机对照交叉研究。
Clin Pract. 2023 Jun 6;13(3):684-700. doi: 10.3390/clinpract13030063.
8
Pharmacokinetics of Antidepressants in Pregnancy.抗抑郁药在妊娠期的药代动力学。
J Clin Pharmacol. 2023 Jun;63 Suppl 1(Suppl 1):S137-S158. doi: 10.1002/jcph.2282.
9
Precision Medicine in Antidepressants Treatment.精准医疗在抗抑郁药物治疗中的应用。
Handb Exp Pharmacol. 2023;280:131-186. doi: 10.1007/164_2023_654.
10
Lower sertraline plasma concentration in patients co-medicated with clozapine-Implications for pharmacological augmentation strategies in schizophrenia.氯氮平合并治疗患者的舍曲林血浆浓度较低——对精神分裂症药物增效策略的影响。
Pharmacol Res Perspect. 2023 Apr;11(2):e01065. doi: 10.1002/prp2.1065.
本文引用的文献
1
CYP2C19 variation and citalopram response.CYP2C19 变异与西酞普兰反应。
Pharmacogenet Genomics. 2011 Jan;21(1):1-9. doi: 10.1097/fpc.0b013e328340bc5a.
2
Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.抗抑郁治疗中自杀意念增加的全基因组关联研究。
Pharmacogenomics J. 2012 Feb;12(1):68-77. doi: 10.1038/tpj.2010.70. Epub 2010 Sep 28.
3
Association between CYP2C19*17 and metabolism of amitriptyline, citalopram and clomipramine in Dutch hospitalized patients.CYP2C19*17 与阿米替林、西酞普兰和氯米帕明在荷兰住院患者体内代谢的相关性。
Pharmacogenomics J. 2011 Oct;11(5):359-67. doi: 10.1038/tpj.2010.39. Epub 2010 Jun 8.
4
MRP1 polymorphisms associated with citalopram response in patients with major depression.MRP1 多态性与抑郁症患者西酞普兰反应相关。
J Clin Psychopharmacol. 2010 Apr;30(2):116-25. doi: 10.1097/JCP.0b013e3181d2ef42.
5
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.GENDEP 项目中抗抑郁反应的全基因组药物遗传学。
Am J Psychiatry. 2010 May;167(5):555-64. doi: 10.1176/appi.ajp.2009.09070932. Epub 2010 Apr 1.
6
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.细胞色素 P450 酶的遗传多态性影响抗抑郁药艾司西酞普兰的代谢和治疗反应。
Pharmacogenomics. 2010 Apr;11(4):537-46. doi: 10.2217/pgs.09.168.
7
Pharmacogenetics studies in STAR*D: strengths, limitations, and results.STAR*D 中的药物遗传学研究：优势、局限性和结果。
Psychiatr Serv. 2009 Nov;60(11):1446-57. doi: 10.1176/appi.ps.60.11.1446.
8
A genomewide association study of citalopram response in major depressive disorder.一项关于西酞普兰治疗重度抑郁症反应的全基因组关联研究。
Biol Psychiatry. 2010 Jan 15;67(2):133-8. doi: 10.1016/j.biopsych.2009.08.029.
9
Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.年龄、体重和 CYP2C19 基因型对艾司西酞普兰暴露的影响。
J Clin Pharmacol. 2010 Jan;50(1):62-72. doi: 10.1177/0091270009337946. Epub 2009 Oct 19.
10
Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram.评价性别及 CYP2C19 和 CYP2D6 多态性对西酞普兰处置的影响。
Eur J Pharmacol. 2010 Jan 25;626(2-3):200-4. doi: 10.1016/j.ejphar.2009.10.007. Epub 2009 Oct 21.
Zotero 插件